06 Nov
|
Amplitude Venture Capital
|
Winnipeg
06 Nov
Amplitude Venture Capital
Winnipeg
Develops and leads insect biology and bioassay development for VLP delivery and bioinsecticidal activity. Designs and conducts cell-based and whole-insect assays to evaluate VLP efficacy in pest insects.
📌 Associate Scientist, Non-Clinical Pharmacology (Winnipeg)
🏢 Amplitude Venture Capital
📍 Winnipeg